{"disease":{"id":"fgfr-mutations","name":"fgfr mutations"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04003623","title":"Efficacy and Safety of Pemigatinib in Participants With Solid Tumors With FGFR Mutations or Translocations (FIGHT-208)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Incyte Corporation","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}